Pain management is indeed a critical aspect of cancer care. Chronic pain can significantly affect the quality of life of cancer patients and survivors. The…
The clinical trial reported by McGregor et al. seems to be a significant step in treating refractory metastatic urothelial carcinoma (UC). The use of combination…
The news about pembrolizumab offering a survival benefit as an adjuvant treatment for kidney cancer is indeed a significant development in the field of oncology.…
Renal cell carcinoma (RCC) is indeed the most common type of kidney cancer in adults, accounting for approximately 90% of all cases. RCC incidence varies…
The CheckMate 040 study is a phase 1/2 clinical trial investigating the safety and efficacy of nivolumab, with or without ipilimumab, in patients with advanced…
POLE and POLD1 are genes that encode for the catalytic subunits of DNA polymerases epsilon and delta, respectively. These polymerases are involved in DNA replication…
This information will be used to contact you